RBM5 identified as key regulator of HOXA9 in acute myeloid leukemia
The protein HOXA9 is overexpressed in most acute myeloid leukemia (AML) cases and is associated with poor patient outcomes.
Source: news-medical.net
%2c_analyze_by_microscope-Jarun_Ontakrai_8864dd9cfb3b4dff9a913aede7a7c915-620x480.jpg)
Depei Wu News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Depei Wu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Depei Wu Today - Breaking & Trending Today
Antengene Announces Commercial - GuruFocus.com
GuruFocus Article or News written by PRNewswire and the topic is about:
Source: gurufocus.com
Antengene Announces Commercial Availability of XPOVIO® (Selinexor), for the Treatment of Relapsed/Refractory Multiple Myeloma, Prescribed for the First Time Across Mainland China
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...
Source: prnewswire.com
Antengene Announces Approval of the Phase II Study of Selinexor for the Treatment of Myelofibrosis in China
/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing...
Source: prnewswire.com
Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines
Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines News provided by Share this article Share this article SHANGHAI and HONG KONG, May 5, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that the Chinese Society of Clinical Oncology (CSCO), the most prominent organization in oncology in China, added multiple selinexor re...
Source: prnewswire.com